| Product Code: ETC9959527 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States saw a significant increase in arterial stents import shipments in 2024, with top exporting countries being Ireland, Germany, Switzerland, Metropolitan France, and the UK. The market concentration, as measured by the HHI, reached very high levels in 2024, indicating a high level of dominance by key suppliers. The compound annual growth rate (CAGR) from 2020 to 2024 was strong at 10.05%, with a notable growth rate of 16.42% from 2023 to 2024, pointing towards a robust and expanding market for arterial stents in the US.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Arterial Stents Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Arterial Stents Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Arterial Stents Market - Industry Life Cycle |
3.4 United States (US) Arterial Stents Market - Porter's Five Forces |
3.5 United States (US) Arterial Stents Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Arterial Stents Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Arterial Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in the US |
4.2.2 Technological advancements in arterial stent design and materials |
4.2.3 Growing adoption of minimally invasive procedures in cardiology |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval |
4.3.2 High costs associated with arterial stent procedures |
4.3.3 Competition from alternative treatment methods such as medication and bypass surgery |
5 United States (US) Arterial Stents Market Trends |
6 United States (US) Arterial Stents Market, By Types |
6.1 United States (US) Arterial Stents Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Arterial Stents Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Arterial Stents Market Revenues & Volume, By Coronary Stents, 2021- 2031F |
6.1.4 United States (US) Arterial Stents Market Revenues & Volume, By Peripheral Stents, 2021- 2031F |
6.2 United States (US) Arterial Stents Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Arterial Stents Market Revenues & Volume, By Coronary Artery, 2021- 2031F |
6.2.3 United States (US) Arterial Stents Market Revenues & Volume, By Carotid Artery, 2021- 2031F |
6.2.4 United States (US) Arterial Stents Market Revenues & Volume, By Iliac Artery, 2021- 2031F |
6.2.5 United States (US) Arterial Stents Market Revenues & Volume, By Femoral & Popliteal Artery, 2021- 2031F |
7 United States (US) Arterial Stents Market Import-Export Trade Statistics |
7.1 United States (US) Arterial Stents Market Export to Major Countries |
7.2 United States (US) Arterial Stents Market Imports from Major Countries |
8 United States (US) Arterial Stents Market Key Performance Indicators |
8.1 Average selling price (ASP) of arterial stents |
8.2 Number of new product launches in the arterial stents market |
8.3 Adoption rate of drug-eluting stents over bare-metal stents |
8.4 Number of clinical trials evaluating the efficacy of different types of arterial stents |
9 United States (US) Arterial Stents Market - Opportunity Assessment |
9.1 United States (US) Arterial Stents Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Arterial Stents Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Arterial Stents Market - Competitive Landscape |
10.1 United States (US) Arterial Stents Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Arterial Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |